Clinical Trial Update: G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response [Phase 2]

View source ↗

Summary

A phase 2 randomized trial evaluated G-CSF for amyotrophic lateral sclerosis, focusing on clinical response. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: Peking University | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED